B. Dahlof

发表

Infrared Laser Therapy for Ischemic Stroke: A New Treatment Strategy: Results of the NeuroThera Effectiveness and Safety Trial–1 (NEST-1)

Marc Fisher, Uri Oron, M. Fisher, 2007, Stroke.

Cardiovascular morbidity and mortality in the losartan intervention for end point reduction in hypertension study (LIFE): a randomised trial against atenolol☆

B. Dahlof, B. Devereux, S. Kjeldsen, 2002 .

Blood pressure measurement reliability among different racial-ethnic groups in a stroke prevention study

P. Gorelick, C. Estol, Renee' H. Martin, 2014, Blood pressure monitoring.

Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration.

R. Collins, B. Davis, C. Bulpitt, 1998, Journal of hypertension.

Effectiveness and Safety of Transcranial Laser Therapy for Acute Ischemic Stroke

Marc Fisher, Jackson Streeter, Dietmar Schneider, 2009, Stroke.

Transcranial Laser Therapy in Acute Stroke Treatment: Results of Neurothera Effectiveness and Safety Trial 3, a Phase III Clinical End Point Device Trial

Majaz Moonis, Christian Weimar, Carlos Molina, 2014, Stroke.

Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension

N. Poulter, P. Sever, H. Wedel, 2009, Journal of hypertension.

The diabetes subgroup baseline characteristics of the Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension (ACCOMPLISH) trial.

G. Bakris, B. Pitt, V. Shi, 2008, Journal of the cardiometabolic syndrome.

Comparison of benazepril plus amlodipine or hydrochlorothiazide in high-risk patients with hypertension and coronary artery disease.

G. Bakris, B. Pitt, T. Hua, 2013, The American journal of cardiology.

Criteria for an informative trial of left ventricular hypertrophy regression.

R. Devereux, B. Dahlof, 1994, Journal of human hypertension.

DETERMINANTS OF NEW-ONSET DIABETES AMONG 19,257 HYPERTENSIVE PATIENTS RANDOMISED IN THE ASCOT-BPLA TRIAL AND THE RELATIVE INFLUENCE OF ANTIHYPERTENSIVE MEDICATION

N. Poulter, P. Sever, J. Dobson, 2008 .

Losartan intervention for endpoint reduction in hypertension (the life study)

B. Dahlof, 1996 .

[PP.02.17] SUCCESSFUL COMPLETION OF A PHASE I, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, SINGLE ASCENDING DOSE TRIAL FOR THE FIRST IN CLASS ANGIOTENSIN AT2-RECEPTOR AGONIST COMPOUND 21

M. Scheinin, P. Korhonen, T. Unger, 2017 .

Lisinopril or nifedipine in essential hypertension? A Norwegian multicenter study on efficacy, tolerability and quality of life in 828 patients.

S. Tretli, B. Dahlof, I. Os, 1991, Journal of hypertension.

Systolic blood pressure and cardiovascular outcomes during treatment of hypertension.

G. Bakris, B. Pitt, T. Hua, 2013, The American journal of medicine.

The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closure.

R. Collins, M. Caulfield, M. Nieminen, 2008, European heart journal.

Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial

G. Bakris, B. Pitt, K. Jamerson, 2013, The Lancet.

Relations of diastolic left ventricular filling to systolic chamber and myocardial contractility in hypertensive patients with left ventricular hypertrophy (The PRESERVE Study).

C. Lau, R. Devereux, G. de Simone, 1999, The American journal of cardiology.

Eff ects of body size and hypertension treatments on cardiovascular event rates : subanalysis of the ACCOMPLISH randomised controlled trial

G. Bakris, B. Pitt, K. Jamerson, 2012 .

The Effects of Losartan Compared to Atenolol on Stroke in Patients With Isolated Systolic Hypertension and Left Ventricular Hypertrophy. The LIFE Study

M. Nieminen, S. Oparil, R. Devereux, 2005, Journal of clinical hypertension.

Influence of diabetes on efficacy of aliskiren, losartan or both on left ventricular mass regression

S. Solomon, A. Pouleur, M. Takeuchi, 2012, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy

A. Zanchetti, Cheuk-Man Yu, V. Barrios, 2002, Journal of hypertension.

Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH Substudy

G. Bakris, B. Pitt, T. Hua, 2016, Journal of clinical hypertension.

Antihypertensive effect of a new dihydropyridine calcium antagonist, PN 200-110 (isradipine), combined with pindolol.

L. Hansson, B. Dahlof, 1987, American Journal of Cardiology.

Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase

R. Collins, N. Poulter, P. Sever, 2017, The Lancet.

Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial).

D. Levy, M. Pfeffer, R. Devereux, 1996, The American journal of cardiology.

Metabolic Syndrome, Independent of Its Components, Is a Risk Factor for Stroke and Death But Not for Coronary Heart Disease Among Hypertensive Patients in the ASCOT-BPLA

N. Poulter, P. Sever, B. Dahlof, 2010, Diabetes Care.

Renal outcomes in hypertensive Black patients at high cardiovascular risk.

G. Bakris, B. Pitt, R. Devereux, 2012, Kidney international.

Coronary heart disease benefits from blood pressure and lipid-lowering.

N. Poulter, P. Sever, H. Wedel, 2009, International journal of cardiology.

Renal outcomes in hypertensive Black patients at high cardiovascular risk.

G. Bakris, B. Pitt, S. Kjeldsen, 2012, Kidney international.

Male gender and chronic obstructive pulmonary disease predict a poor clinical response in patients undergoing cardiac resynchronisation therapy

B. M. Dalen, J. Daubert, D. Atar, 2011, International journal of clinical practice.